CD200AR-L: mechanism of action and preclinical and clinical insights for treating high-grade brain tumors

Christopher Moertel, Francisco Martinez-Puerta, Grace G.Elizabeth Pluhar, Maria Graciela Castro, Michael Olin

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations
Original languageEnglish (US)
JournalExpert Opinion on Investigational Drugs
DOIs
StatePublished - 2022
Externally publishedYes

Keywords

  • CD200
  • Immune checkpoint
  • glioblastoma
  • immunotherapy

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this